PRE
Prenetics Global LtdKey Statistics
About Prenetics Global Ltd
Prenetics Global Ltd (PRE) is a premier health technology innovator focused on delivering advanced genetic and diagnostic testing solutions that empower consumers and healthcare professionals with critical health insights. With a diverse portfolio of state-of-the-art testing services and integrated digital health offerings, the company has seen significant international growth, fueled by strategic partnerships and a strong commitment to ongoing research and development. As a frontrunner in the personalized medicine space, Prenetics is ideally positioned to capitalize on the increasing demand for accessible and actionable health information, representing a compelling investment opportunity in the dynamic healthcare landscape.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.94M |
| EBITDA | $-32.97M |
| Operating Margin | -33.30% |
| Return on Equity | -31.80% |
| Return on Assets | -11.00% |
| Revenue/Share (TTM) | $6.57 |
| Book Value | $10.89 |
| Price-to-Book | 1.78 |
| Price-to-Sales (TTM) | 3.36 |
| EV/Revenue | 2.711 |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | $15.29M |
| Float | $11.92M |
| % Insiders | 17.18% |
| % Institutions | 14.03% |
Historical Volatility
Volatility is currently contracting